Hansa Biopharma Reports Fourth Quarter and Full Year 2024 ...

Hansa Biopharma AB Sweden

Waters New Bioseparations Tools Accelerate and Improve Development ...

Waters Corporation California

Avenzo Therapeutics and DualityBio Announce Exclusive Global ...

Duality Biotherapeutics New Jersey China

Estableciendo un nuevo estándar para las fábricas inteligentes ...

Angel Yeast China New York

Industrial Enzymes Market worth $12.01 billion by 2030- ...

MarketsandMarkets United States of America United Kingdom

Plastic Additives Market Size to Grow USD 83.8 Billion by ...

Valuates Reports United Kingdom United States of America India

Tsingke Successfully Showcases Innovations at BIO-Europe ...

Tsingke Biotechnology Co., Ltd. China New York Sweden

Établir une nouvelle norme pour les usines intelligentes ...

Angel Yeast China New York

STORM Therapeutics Presented Interim Phase 1 Clinical Data ...

STORM Therapeutics England United States of America United Kingdom California

Angel Yeast expandiert in Forschung Entwicklung und Produktion ...

Angel Yeast China

Peptide Synthesis Market to Reach USD 1.12 Billion by 2031 ...

Market Research Intellect Delaware United States of America United Kingdom

Allozymes and Bonumose Collaborate to Accelerate Enzyme ...

Allozymes New York Singapore

Mission Therapeutics announces publication in Nature Reviews ...

Mission Therapeutics United Kingdom United States of America

Mission Therapeutics raises £25.2 million to progress clinical ...

Mission Therapeutics England United Kingdom

STORM Therapeutics to Present Findings on its First-in-Class ...

STORM Therapeutics United States of America United Kingdom England

Specialty Enzymes Market to Surpass USD 10.4 Billion by ...

Transparency Market Research United States of America United Kingdom

Mission Therapeutics to Present Abstract at American Society ...

Mission Therapeutics United Kingdom United States of America

DNA Synthesizer Market worth $754.55 Mn by 2031 - Explained ...

InsightAce Analytic Pvt. Ltd United States of America United Kingdom

Landmark New Publication: the Forgotten Biochemistry 101 ...

TrialSite News Utah

IVD Reagents Market to be Worth $79.76 Billion by 2031 - ...

Meticulous Market Research Pvt. Ltd. United States of America United Kingdom California

Hansa Biopharma Reports Second Quarter and Interim January-June ...

Hansa Biopharma AB Sweden

Clean Label Starch Market to Reach USD 2.6 Billion by 2032 ...

Credence Research Inc. India United States of America United Kingdom

Myocarditis Treatment Market Size is Projected to Reach ...

Transparency Market Research United States of America United Kingdom

Tony Kouzarides Founder of STORM Therapeutics Awarded British ...

STORM Therapeutics United States of America United Kingdom England

Hansa Biopharma presents positive outcomes of five-year ...

Hansa Biopharma AB Sweden

Global Glucose Biosensor Market Size to hit $21.3 billion ...

Coherent Market Insights United States of America United Kingdom

Clinical Biomarkers Market worth $47.25 Bn by 2031 - Exclusive ...

InsightAce Analytic Pvt. Ltd New Jersey United States of America United Kingdom

Acurx Announces Publication of Positive Results from an ...

Acurx Pharmaceuticals, Inc. New York

Enzymatica AB's Interim report Q3/2024: Focus on developing ...

Enzymatica AB Sweden

Avenzo Therapeutics Announces Global License of AVZO-021 ...

Allorion Therapeutics Massachusetts California

Hansa Biopharma Reports Second Quarter 2024 Financial Results ...

Hansa Biopharma AB Sweden

Angel Yeast Brings Together Innovative Consortium to Build ...

Angel Yeast China

Mission Therapeutics granted MHRA Clinical Trial Authorisation ...

Mission Therapeutics United States of America England United Kingdom

Angel Yeast bringt innovatives Konsortium zum Aufbau eines ...

Angel Yeast China

Zymo Research Pioneers a Breakthrough in Large-scale Animal-free ...

Zymo Research Corp.

Zymo Research Unveils PureRec DSN: The Most Selective Duplex-Specific ...

Zymo Research Corp.

Norgine welcomes PBS listing in Australia of IFINWIL® for ...

Norgine Australia

Dairy Cultures Market to Reach $1 473.2 Million Globally ...

Allied Market Research United States of America United Kingdom

Nebulizer Market to Reach $2.3 Billion by 2032 exhibiting ...

Allied Market Research United States of America United Kingdom

Bioburden Testing Market worth $2.59 billion by 2031 Owing ...

Coherent Market Insights United States of America United Kingdom

Fertilizers Market worth $281.56 billion by 2030- Exclusive ...

MarketsandMarkets United States of America United Kingdom

Oncology Precision Medicine Market Size to Hit USD 364 Billion ...

Roots Analysis United States of America United Kingdom

Textile Enzymes Market to Reach USD 0.36 Billion by 2031 ...

Market Research Intellect United Kingdom United States of America

Total Investment of Approx. USD 7.3 Million in Malaria and ...

GHIT Fund Japan

BioInnovation Institute provides EUR 7.8M in financial support ...

BioInnovation Institute Denmark United Kingdom United States of America

Top 10 Food Safety Testing and Technologies Trends worth ...

MarketsandMarkets United Kingdom United States of America

Clarivate Reveals Citation Laureates 2024

Clarivate Plc

England's NICE recommends FILSPARI® as a treatment option ...

Vifor International AG (CSL Vifor) Travere Therapeutics, Inc.

Hansa Biopharma Reports First Quarter and Interim January-March ...

Hansa Biopharma AB Sweden

Hansa Biopharma to attend 2025 J.P. Morgan Healthcare Conference ...

Hansa Biopharma AB Sweden

Livestock Diagnostics Market to be Worth $2.56 billion in ...

Meticulous Market Research Pvt. Ltd. United States of America United Kingdom

BioArctic's Capital Markets Day 2025 - entering a new era ...

BioArctic Sweden

Einen neuen Standard für intelligente Fabriken setzen: ...

Angel Yeast China New York

Global Bio-refinery Market to Reach $85.08 Billion by 2030 ...

Kings Research United States of America United Kingdom

Future of Feed Industry Outlook 2024 - Navigating the Culinary ...

MarketsandMarkets United States of America United Kingdom

Hansa Biopharma completes enrolment in European Phase 3 ...

Hansa Biopharma AB Sweden

Acurx Announces Publication of Positive Results from an ...

Acurx Pharmaceuticals, Inc. New York

Avenzo Therapeutics Announces Global License of AVZO-021 ...

Allorion Therapeutics Massachusetts California

Total Investment of Approx. USD 7.3 Million in Malaria and ...

GHIT Fund Japan

Clarivate Reveals Citation Laureates 2024

Clarivate Plc

Chiesi Global Rare Diseases Awards Research Grants to Advance ...

Chiesi Global Rare Diseases a business unit of the Chiesi Group established to deliver innovative solutions for people living with rare diseases today announced the recipients ...

Chinesische und europäische Unternehmen kommen in Stuttgart ...

Chinesische und europäische Unternehmen kommen in Stuttgart zusammen, um über ESG-Kooperationen zu sprechen

Chinese and European Enterprises Gather in Stuttgart to ...

The 2nd Sino-European Corporate ESG Best Practice Conference, hosted by the Chinese Consulate General in Frankfurt, was held on June 26th, 2025 in Stuttgart, Germany.

Studie: Beta-Carotin kann Enzymaktivität steigern

Forscher der Technischen Universität München haben herausgefunden, dass Beta-Carotin die Aktivität bestimmter Enzyme erhöhen kann.

EQS-News: Erfahrene Biotechnologie-Expertin neu im Aufsichtsrat ...

Erfahrene Biotechnologie-Expertin neu im Aufsichtsrat der BRAIN Biotech AG EQS-News: BRAIN Biotech AG / Schlagwort(e): Personalie Erfahrene Biotechnologie-Expertin neu im ...

Erfahrene Biotechnologie-Expertin neu im Aufsichtsrat der ...

BRAIN Biotech AG / DE0005203947

REPRONOVO ANNOUNCES FIRST PARTICIPANT INCLUDED IN U.S. PHASE ...

ReproNovo SA

Original-Research: Vidac Pharma Holding Plc (von Sphene ...

Original-Research: Vidac Pharma Holding Plc - from Sphene Capital GmbH 24.06.2025 / 13:47 CET/CEST Dissemination of a Research transmitted by EQS News - a service of EQS Group. ...

Immunic Reports New Positive Long-Term Open-Label Extension ...

Immunic AG / US4525EP1011

Ferrer Receives FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy

FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025

Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse? G sTREM2 Assay for Research Use Only

Immunic to Participate in Investor Scientific and Industry ...

Immunic AG / US4525EP1011

EQS-News: BRAIN Biotech AG berichtet finale Halbjahreszahlen ...

BRAIN Biotech AG berichtet finale Halbjahreszahlen für das Geschäftsjahr 2024/25 EQS-News: BRAIN Biotech AG / Schlagwort(e): Halbjahresergebnis/Halbjahresbericht BRAIN Biotech ...

BRAIN Biotech AG berichtet finale Halbjahreszahlen für ...

BRAIN Biotech AG / DE0005203947

Rubedo Life Sciences Announces First Patient Dosed with Lead Drug Candidate RLS-1496 the First GPX4 Modulator Targeting Pathologic Senescent Cells To Enter Phase 1 Clinical ...

Journal of Critical Care publishes positive results from ...

Adrenomed AG

EQS-News: BRAIN Biotech informiert über Erwerb von Minderheitsanteilen ...

BRAIN Biotech informiert über Erwerb von Minderheitsanteilen neue Produktionsstätte in Kontinentaleuropa und Ausbau seines Kompetenzzentrums für Backapplikationen EQS-News: ...

BRAIN Biotech informiert über Erwerb von Minderheitsanteilen ...

BRAIN Biotech AG / DE0005203947

BRAIN Biotech announces buy-out of minorities new continental ...

BRAIN Biotech AG / DE0005203947

Immunic to Participate in Scientific and Industry Conferences ...

Immunic AG / US4525EP1011

Immunic Announces Vidofludimus Calcium Reduced Risk of Disability ...

Immunic AG / US4525EP1011

XORTX gibt Erteilung eines europäischen Patents bekannt ...

XORTX Therapeutics Inc. / CA98420Q3061

GNW-News: OBI Pharma kündigt Posterpräsentationen auf ...

TAIPEH, Taiwan, April 24, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc.

GNW-News: Santhera informiert über den kommerziellen Rollout ...

GNW-News: Santhera informiert über den kommerziellen Rollout von AGAMREE®

Immunic Inc. Announces Closing of $5.1 Million Registered ...

Immunic AG / US4525EP1011

Immunic Inc. Announces Pricing of $5.1 Million Registered ...

Immunic AG / US4525EP1011

Stopfleber aus dem Labor: Foie Gras ohne Tierquälerei. ...

Für Stopfleber werden Gänse und Enten extrem gequält.

Experten-Warnung: Mpox könnte zu ernster Bedrohung werden. ...

Ist doch weit weg, dieses Mpox.

Immunic Inc. to Participate in Scientific and Industry Conferences ...

Immunic AG / US4525EP1011

BIOVERSYS ANNOUNCES IMPORTANT BV100 PATENT GRANTED BY CHINESE ...

BioVersys AG / CH0210362643

Heidelberg Pharma to Present Data from its ADC Technology ...

Heidelberg Pharma AG / DE000A11QVV0

Gain Therapeutics Doses First Participant in Phase 1b Clinical ...

Interim Analysis Expected End of 2Q 2025

Very good annual results 2024 demonstrate successful implementation ...

Henkel AG & Co. KGaA / DE0006048432

GNW-News: Handelsupdate für das Gesamtjahr. 53 LR Pratteln ...

Ad hoc Ankündigung gemäß Art.

Immunic to Participate in Scientific and Investor Conferences ...

Immunic AG / US4525EP1011

Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS ...

Immunic AG / US4525EP1011

EQS-News: Bio-Gate AG: Medizinisches CBD-Muskelpflege-Gel ...

Bio-Gate AG: Medizinisches CBD-Muskelpflege-Gel von Bio-Gate erhält in klinischer Studie Testergebnis sehr gut EQS-News: Bio-Gate AG / Schlagwort(e): Studienergebnisse/Sonstiges ...

Bio-Gate AG: Medizinisches CBD-Muskelpflege-Gel von Bio-Gate ...

Bio-Gate AG / DE000BGAG981